skip to Main Content

May 19, 2023
TAG’s Submission to OHCHR for GA78 Report
Letter / Comment
TAG recently submitted this input for the Office of the High Commissioner on Human Rights (ONHCR) Independent Expert on Foreign Debt and Human Rights thematic report for the UN General Assembly 78 later this year.

May 9, 2023
Research in Action Awards 2023
Save the date for Monday, October 19! TAG’s 2023 Research in Action Awards will honor some of the best and brightest activists, scientists, and leaders in the fight to end HIV, tuberculosis, and hepatitis C across the U.S. and around the world.

May 8, 2023
TAG Remarks Delivered at Multistakeholder Hearings, May, 2023
TAG prepared these remarks to deliver at multistakeholder hearings on health held on May 8 and 9, 2023, at the United Nations Headquarters in New York City.

April 19, 2023
Nitrosamines and TB Medicines Information Note and Patient FAQs
In 2020, health authorities and drug manufacturers identified a type of chemical impurity called nitrosamines in rifampicin and rifapentine, two essential medicines used in the treatment and prevention of TB. TAG and IMPAACT4TB project partners have developed several materials to help people affected by TB, advocates, policymakers, and implementers understand…

April 5, 2023
Director of Development
Treatment Action Group (TAG) seeks a dynamic, motivated, and skilled individual to become its Director of Development supporting the organization as it continues to grow.

March 30, 2023
35 Years of Art to End AIDS Exhibition Catalog
TAG is presenting the exhibition “35 Years of Art to End AIDS” at Melissa Morgan Fine Art in Palm Desert, California, from March 17 through April 7, 2023. This exhibit features selected works form our Limited Art Editions collection.

March 28, 2023
The 1/4/6×24 Campaign Coalition Welcomes India’s Rejection of Johnson & Johnson’s Patent Evergreening Tactic
Statement / Press
The Indian Patent Office has taken a laudable step that will pave the way for generic manufacturing of a key tuberculosis (TB) drug.

March 20, 2023
For World TB Day, TB Advocates Demand Universal Access to Shorter, Safer TB Regimens
Statement / Press
On March 24, World Tuberculosis (TB) Day offers an opportunity to take stock of global progress against the deadliest disease in human history. This year, we face a sobering reality: since the start of the COVID-19 pandemic, rates of TB infection and death are higher than they’ve been since the…

March 17, 2023
TAG Applauds Price Reduction of Molbio’s Truenat Diagnostics for Tuberculosis
Statement / Press
Treatment Action Group (TAG) applauds Molbio’s agreement with the Stop TB Partnership, USAID, and the Global Fund to reduce the price of Truenat diagnostic tests for tuberculosis (TB) from US$9 per test to $7.90 per test and to provide quality service and maintenance of Truenat testing instruments globally.

March 14, 2023
TB Vaccine Development: The Next Chapter Starts Now
Webinar / Presentation
On Thursday, April 13, Treatment Action Group (TAG) presented this webinar about important developments in TB vaccine research.

March 13, 2023
1 / 4 / 6 x 24
Inspired by the legacy of Dr. Paul Farmer, the 1 / 4 / 6 x 24 Campaign calls for the “staff, stuff, space, systems and support” necessary to make groundbreaking short-course TB prevention and treatment regimens accessible to all who need them as a human right by the end of…

February 28, 2023
Open Letter: Urgent action necessary to improve equitable access to GeneXpert tuberculosis diagnostics and achieve 1/4/6×24
Letter / Comment
TAG and a coalition of civil society activists, public health leaders, and researchers acting in solidarity with communities affected by tuberculosis sent an open letter to Cepheid calling on the company to take urgent action necessary to improve equitable access to GeneXpert tuberculosis diagnostics and achieve 1/4/6×24.

February 24, 2023
Call for Expression of Interest: Community Advisory Boards to Support Community Engagement in Research under the SMART4TB Project
The SMART4TB Consortium is calling for expressions of interest from multi-national community advisory boards (CAB) or similarly organized civil society organizations within three geographic focus areas to support community engagement in research in a new five-year research project funded by USAID.

February 22, 2023
CROI 2023 Tuberculosis Research Round Up
Statement / Press
Treatment Action Group (TAG) welcomes the tuberculosis (TB) data presented at the 2023 Conference on Retroviruses and Opportunistic Infections (CROI).

February 17, 2023
TB Treatment Trial Results in Context for Communities
Webinar / Presentation
On Tuesday, March 14 at 8:00 am ET, join Treatment Action Group (TAG) and Dr. Jennifer Furin for an overview of key results and breakdown of how they fit into the larger TB policy and research landscapes.

Back To Top